211 related articles for article (PubMed ID: 25443932)
1. Late ureteral obstruction after endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer.
Şencan A; Yıldırım H; Özkan KU; Uçan B; Karkıner A; Hoşgör M
Urology; 2014 Nov; 84(5):1188-93. PubMed ID: 25443932
[TBL] [Abstract][Full Text] [Related]
2. Postoperative ureteral obstruction after endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer (Vantris®).
Alizadeh F; Mazdak H; Khorrami MH; Khalighinejad P; Shoureshi P
J Pediatr Urol; 2013 Aug; 9(4):488-92. PubMed ID: 23219423
[TBL] [Abstract][Full Text] [Related]
3. Vantris vs. deflux for treatment of paediatric vesicoureteral reflux: Efficacy and obstruction risk.
Renaux-Petel M; Grynberg L; Lubet A; Comte D; Liard-Zmuda A
Fr J Urol; 2024 Mar; 34(2):102585. PubMed ID: 38717460
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children.
Kocaoglu C
J Pediatr Surg; 2016 Oct; 51(10):1711-5. PubMed ID: 27117052
[TBL] [Abstract][Full Text] [Related]
5. Early results of endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer.
Şencan A; Uçan B; Evciler H; Serdaroğlu E; Hoşgör M
Urol Int; 2014; 92(2):219-22. PubMed ID: 24335079
[TBL] [Abstract][Full Text] [Related]
6. The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux.
Taşkinlar H; Avlan D; Bahadir GB; Delibaş A; Nayci A
Int Braz J Urol; 2016; 42(3):514-20. PubMed ID: 27286115
[TBL] [Abstract][Full Text] [Related]
7. Prospective study using a new bulking agent for the treatment of vesicoureteral reflux: polyacrylamide hydrogel.
Cloutier J; Blais AS; Moore K; Bolduc S
J Urol; 2013 Sep; 190(3):1034-7. PubMed ID: 23538241
[TBL] [Abstract][Full Text] [Related]
8. Four-Point Injection Technique of Polyacrylate/Polyalcohol Copolymer in Vesicoureteral Reflux After KidneyTransplant.
Çilesiz NC; Onuk Ö; Özkan A; Kalkanlı A; Gezmiş CT; Nuhoĝlu B
Exp Clin Transplant; 2023 May; 21(5):434-440. PubMed ID: 37073991
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).
García-Aparicio L; Blázquez-Gómez E; Martin O; Pérez-Bertólez S; Arboleda J; Soria A; Tarrado X
World J Urol; 2018 Oct; 36(10):1651-1656. PubMed ID: 29725806
[TBL] [Abstract][Full Text] [Related]
10. The use of polyacrylate-polyalcohol copolymer hydrogel in the endoscopic treatment of primary vesicoureteral reflux in children.
Corbetta JP; Bortagaray JI; Weller S; Ruiz J; Burek C; Sager C; Durán V; Lopez JC
J Pediatr Surg; 2015 Mar; 50(3):485-8. PubMed ID: 25746713
[TBL] [Abstract][Full Text] [Related]
11. Late-onset Uretero-vesical Junction Obstruction Following Endoscopic Injection of Bulking Material for the Treatment of Vesico-ureteral Reflux.
Ben-Meir D; Bahouth Z; Halachmi S
Urology; 2017 Mar; 101():60-62. PubMed ID: 27993711
[TBL] [Abstract][Full Text] [Related]
12. Multicenter survey of endoscopic treatment of vesicoureteral reflux using polyacrylate-polyalcohol bulking copolymer (Vantris).
Kocherov S; Ulman I; Nikolaev S; Corbetta JP; Rudin Y; Slavkovic A; Dokumcu Z; Avanoglu A; Menovshchikova L; Kovarskiy S; Skliarova T; Weller S; Bortagaray JI; Lopez JC; Durán V; Burek C; Sager C; Maruhnenko D; Garmanova T; Djamal A; Jovanovic Z; Vacic N; Abu Arafeh W; Chertin B
Urology; 2014 Sep; 84(3):689-93. PubMed ID: 25168553
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for obstructive complications after endoscopic correction of vesico-ureteral reflux using polyacrylate polyalcohol copolymer.
Sizonov VV; Kagantsov IM; Mayr JM; Akramov NR; Pirogov AV; Gasanov ZA
Medicine (Baltimore); 2020 May; 99(22):e20386. PubMed ID: 32481425
[TBL] [Abstract][Full Text] [Related]
14. The comparison of dextranomer/hyaluronic acid and polyacrylate-polyalcohol copolymers in endoscopic treatment of vesicoureteral reflux.
Karakus SC; User İR; Kılıc BD; Akçaer V; Ceylan H; Ozokutan BH
J Pediatr Surg; 2016 Sep; 51(9):1496-500. PubMed ID: 27061353
[TBL] [Abstract][Full Text] [Related]
15. Effect of ureteral reimplantation on prevention of urinary tract infection and renal growth in infants with primary vesicoureteral reflux.
Matsumoto F; Tohda A; Shimada K
Int J Urol; 2004 Dec; 11(12):1065-9. PubMed ID: 15663676
[TBL] [Abstract][Full Text] [Related]
16. Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux.
Chertin B; Natsheh A; Fridmans A; Shenfeld OZ; Farkas A
J Urol; 2009 Oct; 182(4 Suppl):1703-6. PubMed ID: 19692032
[TBL] [Abstract][Full Text] [Related]
17. Acute and delayed vesicoureteral obstruction after endoscopic treatment of primary vesicoureteral reflux with dextranomer/hyaluronic acid copolymer: why and how to manage.
García-Aparicio L; Rodo J; Palazon P; Martín O; Blázquez-Gómez E; Manzanares A; García-Smith N; Bejarano M; de Haro I; Ribó JM
J Pediatr Urol; 2013 Aug; 9(4):493-7. PubMed ID: 23507288
[TBL] [Abstract][Full Text] [Related]
18. New tissue bulking agent (polyacrylate polyalcohol) for treating vesicoureteral reflux: preliminary results in children.
Ormaechea M; Ruiz E; Denes E; Gimenez F; Dénes FT; Moldes J; Amarante A; Pioner G; Dekermacher S; de Badiola F
J Urol; 2010 Feb; 183(2):714-7. PubMed ID: 20022037
[TBL] [Abstract][Full Text] [Related]
19. The long-term incidence of urinary tract infection after endoscopic management of vesicoureteral reflux.
Heckler AM; Sung J; Watters S; Martinez Acevedo A; Conlin M; Skoog S
Urology; 2014 Jun; 83(6):1383-7. PubMed ID: 24685059
[TBL] [Abstract][Full Text] [Related]
20. Can distal ureteral diameter measurement predict primary vesicoureteral reflux clinical outcome and success of endoscopic injection?
Payza AD; Hoşgör M; Serdaroğlu E; Sencan A
J Pediatr Urol; 2019 Oct; 15(5):515.e1-515.e8. PubMed ID: 31420285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
